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Passage	2	 Cells	passaged	after	6	days	at	1:5	and	1:1.67	ratios	 Cells	passaged	after	6	days	at	1:2	ratio	 Cells	passaged	after	6	days	at	1:5	and	1:3	ratios	
Passage	3	 Cells	passaged	after	7	days	at	1:3	and	1:5	ratios	 Cells	passaged	after	6	days	at	1:10	and	1:15	ratios	 Cells	passaged	after	7	days	at	1:3	and	1:5	ratios	
Passage	4	 Cells	passaged	after	3	days	at	1:10	and	1:15	ratios	 Cells	passaged	after	4	days	at	1:10	and	1:15	ratios	 Cells	passaged	after	4	days	at	1:10	and	1:15	ratios	
Passage	5	 Cells	passaged	after	7	days	at	1:10	and	1:15	ratios	 Cells	passaged	after	6	days	at	1:10	and	1:15	ratios	 Cells	passaged	after	6	days	at	1:10	and	1:15	ratios	
Passage	6	 Cells	passaged	after	6	days	to	100	x	20mm	plates	for	storage	preparation	
Storage	 All	three	cell	lines	were	removed	from	plates	and	prepared	for	storage	at	-80°C.		hEPS	cells	to	be	used	for	co-culture	with	cells	from	human	embryo	TE	biopsies	in	preparation	for	single-cell	whole	genome	sequencing.		
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DISCUSSION		 Study	of	early	embryonic	events	is	limited	due	to	a	scarcity	of	biological	materials,	and	legal	and	ethical	restrictions	on	embryo	research.		Research	is	limited	to	the	embryos	that	are	marked	as	morphologically	abnormal,	biopsied	frozen	embryos	that	have	resulted	in	an	aneuploid	genetic	test,	embryos	discarded	on	day	of	transfer,	and	frozen	embryos	that	have	been	donated	following	successful	IVF	treatment.		The	majority	of	these	embryos	donated	to	research	present	initially	with	genetic	abnormalities,	and	the	information	gathered	from	these	samples	should	be	accounted	for	accordingly.		Despite	inherent	challenges,	both	single-cell	whole	genome	sequencing	of	trophectoderm	biopsies	and	hEPS	cell	cultures	could	provide	further	insight	into	how	genetic	aneuploidies	can	affect	embryo	implantation,	cell	fate	decisions,	and	fetal	viability.	Single-cell	whole	genome	sequencing	of	human	embryos	opens	the	door	for	an	alternative	method	of	discerning	the	impact	of	early	meiotic	and	mitotic	genetic	errors.		Deciphering	the	derivation	of	genetic	errors	could	inform	the	determination	of	embryonic	viability.		Little	research	has	been	done	using	NGS	to	visualize	genetic	errors	at	the	level	of	a	single-cell	due	to	challenges	with	genetic	sequencing	techniques,	and	physical	manipulation	of	individual	cells.		Understanding	genetic	variation	at	the	individual	cell	level	could	provide	additional	insight,	not	only	into	the	drivers	of	implantation	failure,	but	also	to	the	merits	and	phenotypic	effects	of	genetic	diversity.		Over-selection	of	embryos	could	result	in	screening	out	embryos	
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that	could	produce	both	genetically	and	phenotypically	normal	offspring.		Studying	the	relationship	between	small-scale	genetic	variation	and	the	success	of	IVF	therapies	could	provide	increased	clarity	for	physicians	with	respect	to	genetic	testing	and	embryo	selection,	while	also	maintaining	genetic	diversity	in	the	population.		In	vitro	models	like	hEPS	cells	can	be	used	to	study	the	cellular	events	that	can	better	inform	genetic	testing	procedures.	Successful	conversion	of	hESC	to	hEPS	cells	creates	a	model	for	the	study	of	early	human	embryonic	events	in	vitro.		hEPS	cells	have	the	ability	to	differentiate	into	trophectoderm,	inner	cell	mass,	and	primitive	endoderm	cell	types	–	the	first	major	hESC	differentiation	point	in	the	development	of	the	human	embryo.		Preliminary	research	into	genetic	expression	patterns	at	this	early	stage	has	indicated	variations	in	genetic	expression	could	support	or	deter	implantation	events	(Petropoulos	et	al.,	2016).		hEPS	cells	have	also	been	co-cultured	with	hESC	cells	on	a	3D	extracellular	matrices,	self-assembling	into	an	early	embryonic	structure,	facilitating	the	visualization	of	early	implantation	checkpoints	(Shahbazi	et	al.,	2016).		It	is	possible	that	hEPS	cells	are	not	identical	to	pre-implantation	cells	in	the	human	embryo,	and	additional	research	is	required	to	determine	whether	genetic	signaling	from	these	cells	could	vary	from	early	human	embryonic	derived	cell	lines.		Detailed	study	of	hEPS	cells	using	RNA	sequencing,	proteomics,	and	metabolomics	could	inform	co-culture	and	embryonic	assembly	research.		Study	of	early	embryonic	differentiation	events	could	help	to	inform	the	study	of	both	
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embryonic	mosaicism	and	of	genetic	testing	to	improve	implantation	outcomes	in	IVF	treatments.			Co-culture	of	trophectoderm	biopsy	cells	with	hEPS	cells	could	create	an	alternative	pathway	for	DNA	amplification.		Currently,	human	trophectoderm	cells	are	unable	to	survive	in	long-term	culture	conditions.		Co-culturing	biopsied	trophectoderm	cells	with	hEPS	cells	of	known	genetic	composition	could	promote	trophectoderm	cell	replication,	amplifying	the	number	of	cells,	and	increasing	NGS	single-cell	whole	genome	sequencing	resolution	of	the	embryo	cell	biopsy.		Additional	hESC	cell	lines	could	also	be	converted	to	hEPS	cells	to	further	refine	growth	conditions	for	hEPS	cells	in	preparation	for	variations	in	co-culture	conditions.		Cells	from	different	trophectoderm	biopsies	could	respond	atypically	in	standardized	culture	conditions,	which	would	require	protocol	adjustment	to	acquire	the	volume	of	DNA	required	for	NGS	analysis.		Most	NGS	platforms	require	hundreds	of	nanograms	to	micrograms	of	input	DNA,	therefore	increasing	the	amount	of	genetic	information	available	could	facilitate	comparison	across	sequencing	platforms	and	standardization	across	IVF	clinics.		Enhancing	and	developing	high-resolution	single	cell	genetic	sequencing	can	help	improve	clinical	decision	making	following	PGD	and	PGS	testing.			As	NGS	testing	becomes	more	widely	utilized	for	applications	in	IVF	and	other	diseases,	costs	will	decrease	such	that	PGD	and	PGS	testing	can	become	standard	of	care	for	IVF	treatments.		The	more	complete	the	picture	available,	protocols	can	be	developed	and	modified	to	create	definitive	screening	criteria	that	
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can	ensure	viable	pregnancies,	but	not	effect	over-selection	or	decreasing	population	genetic	diversity.	PGD	and	PGS	sequencing	of	human	embryo	trophectoderm	biopsies	has	become	simultaneously	more	accessible	and	affordable	to	patients,	while	more	confusing	for	physicians.		The	majority	of	NGS	reports	from	PGD	and	PGS	analyses		will	report	on	the	mosaicism	of	a	sample,	but	there	is	still	disagreement	in	the	medical	community	around	how	to	proceed	with	that	information	(Weissman	et	al.,	2017).		Physicians	generally	agree	that	human	embryos	with	mosaicism	greater	than	50%	are	considered	aneuploid	and	non-transferable,	while	physicians	will	proceed	with	embryos	considered	euploid,	a	mosaicism	less	than	20%.		Consensus	has	yet	to	be	reached	on	embryos	with	mosaicism	between	20-50%,	with	early	results	demonstrating	implantation	is	possible	albeit	at	lower	rates	than	a	euploid	embryo	(Capalbo	&	Rienzi,	2017;	Fragouli	et	al.,	2017;	Maxwell	et	al.,	2016;	Weissman	et	al.,	2017).		Furthermore,	the	trophectoderm	cells	biopsied	from	the	embryo	represent	a	subset	of	the	cells	that	comprise	the	embryo	as	a	whole.		Analysis	of	multiple	biopsies	of	the	same	embryo	demonstrate	that	mosaicism	levels	could	vary	substantially	across	biopsies,	and	the	result	of	a	PGD	or	PGS	test	may	not	be	representative	of	the	overall	health	of	an	embryo	(Kushnir	et	al.,	2018).		There	is	some	evidence	that	shows	that	an	aneuploid	trophectoderm	biopsy	is	indicative	of	overall	embryo	aneuploidy	in	58%	of	embryos	(Munné,	Grifo,	&	Wells,	2016;	Garrisi	et	al.,	2016).		An	inherent	difficulty	of	using	trophectoderm	biopsies	is	that	they	are	cells	that	will	ultimately	comprise	the	placenta	layer,	as	opposed	to	the	inner	cell	
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mass	cells	that	will	develop	into	the	fetus.		Analysis	of	single-cell	whole	genome	genetic	sequencing	data	of	both	trophectoderm	biopsies	and	whole	human	embryos	could	provide	additional	insight	into	the	distribution	of	human	embryonic	mosaicism	and	the	best	protocols	for	PGD	and	PGS	testing.		More	detailed	research	into	specific	protein	level	analysis	or	RNA	sequencing	of	embryos	at	different	developmental	checkpoints	would	also	be	beneficial	to	explore	whether	it	is	possible	to	find	a	genetic	signature	that	could	correspond	directly	to	embryonic	implantation	probability	and	in	utero	embryo	viability.		High-resolution	genetic	sequencing	could	then	be	standardized	to	be	used	as	an	additional	embryo	grade	to	improve	embryo	selection,	and	thus	implantation	outcomes	for	IVF	treatments.	Finally,	increased	efficiency	of	IVF	treatments	to	reduce	costs	and	make	them	more	broadly	available	to	patients	who	require	assistance.		Increased	utilization	could	also	increase	PGD	and	PGS	testing	that	would	increase	the	amount	of	information	available	for	research.		Additional	information	can	be	used	to	inform	the	treatment	process	to	better	serve	all	patients.			Ultimately,	information	sharing	across	countries	and	treatment	centers	could	create	a	standardized	approach	to	genetic	screening.		Currently	there	is	a	lack	of	agreement	across	the	medical	and	research	communities	around	the	standard	of	care	for	IVF	patients	due	to	a	lack	of	basic	science	and	clinical	research	(Weissman	et	al.,	2017).		Standardizing	an	approach	and	creating	consensus	could	drive	improved	outcomes	for	all	IVF	patients.				Agreement	amongst	physicians	would	
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decrease	the	risks	of	multiple	pregnancies,	emotional	and	psychological	trauma,	improve	infant	mortality	and	outcomes	worldwide.	While	enhancing	the	efficacy	of	PGD	and	PGS	testing	of	human	embryos	can	improve	clinical	outcomes,	the	selection	of	embryos	raises	pressing	ethical	questions.		Human	embryonic	mosaicism	can	present	as	a	wide	range	of	genetic	errors	across	the	human	genome.		While	some	chromosome	deletions	or	additions	may	result	in	an	inviable	embryo,	other	genetic	abnormalities	create	viable	embryos	but	with	significant	phenotypic	consequences.		SNPs	and	chromosomal	translocations	may	also	result	in	viable	embryos,	but	could	result	in	increased	genetic	predisposition	to	disease.		It	is	possible	that	a	genetic	signature	of	genetic	replication	errors	could	signal	viability	of	a	human	embryo,	but	viability	must	be	considered	in	parallel	long-term	health	of	the	fetus.		Genetic	counseling	with	both	physicians	and	patients	is	necessary	before	taking	action	in	IVF	decision	making.				
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